The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report for 2013. The Board has decided to present the Annual Report 2013 to the ordinary general assembly on 13th May 2014. The Annual Report 2013 is attached.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Recommended Reading
-
An extraordinary general meeting of PCI Biotech Holding ASA (“the Company”) took place today, 16 March 2026. All the matters on the agenda were approved in accordance with the proposals set out in...
Read More -
Oslo, Norway 23 February 2026 – An extraordinary general meeting of PCI Biotech Holding ASA (‘PCI Biotech’ or ‘Company’) will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on...
Read More